Formulation Development and Evaluation of Fast Disintegrating Tablet of Cetirizine Hydrochloride : A Novel Drug Delivery for Pediatrics and Geriatrics

Recent developments in fast disintegrating tablets have brought convenience in dosing to pediatric and elderly patients who have trouble in swallowing tablets. The objective of the present study was to prepare the fast disintegrating tablet of Cetirizine Hydrochloride for allergic and respiratory disorders. As precision of dosing and patient's compliance become important prerequisite for a long-term treatment, there is a need to develop a formulation for this drug which overcomes problems such as difficulty in swallowing, inconvenience in administration while travelling, and patient's acceptability. Hence, the present investigation was undertaken with a view to develop a fast disintegrating tablet of Cetirizine Hydrochloride which offers a new range of products having desired characteristics and intended benefits. Superdisintegrants such as Sodium Starch Glycolate were optimized. Different binders were optimized along with optimized superdisintegrant concentration. The tablets were prepared by direct compression technique. The tablets were evaluated for hardness, friability, weight variation, wetting time, disintegration time and uniformity of content. Optimized formulation was evaluated by in vitro dissolution test, drug excipient compatibility and accelerated stability study. It was concluded that fast disintegrating tablets of Cetirizine Hydrochloride were formulated successfully with desired characteristics which disintegrated rapidly, provide rapid onset of action, and enhance the patient convenience and compliance.

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:2014

Enthalten in:

Journal of pharmaceutics - 2014(2014) vom: 15., Seite 808167

Sprache:

Englisch

Beteiligte Personen:

Sharma, Deepak [VerfasserIn]
Singh, Mankaran [VerfasserIn]
Kumar, Dinesh [VerfasserIn]
Singh, Gurmeet [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Completed 11.11.2015

Date Revised 30.09.2020

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1155/2014/808167

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM254518605